caa a22 4500 47580595X CHVBK 20180406123746.0 cr unu---uuuuu 170329e20000601xx s 000 0 eng 10.1023/A:1026583911941 doi (NATIONALLICENCE)springer-10.1023/A:1026583911941 Neeman Michal Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel aut Preclinical MRI Experience in Imaging Angiogenesis [Elektronische Daten] [Michal Neeman] Magnetic resonance imaging (MRI) provides a range of non-invasive measures for visualization of tumor angiogenesis in the clinic as well as in experimental tumor models. MRI methods were developed for assessment of spatial and temporal changes in perfusion, blood volume fraction, vascular permeability, vascular function, vascular maturation, vessel diameter and tortuosity. Molecular targeted contrast agents were used for mapping specific markers of neovasculature. These approaches were applied for analysis of a number of regulatory mechanisms controlling tumor angiogenesis and for preclinical evaluation of tumor response to antiangiogenic agents. Kluwer Academic Publishers, 2000 angiogenesis nationallicence MRI nationallicence permeability nationallicence in vivo imaging nationallicence hypoxia nationallicence Cancer and Metastasis Reviews Kluwer Academic Publishers 19/1-2(2000-06-01), 39-43 0167-7659 19:1-2<39 2000 19 10555 https://doi.org/10.1023/A:1026583911941 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1023/A:1026583911941 text/html Onlinezugriff via DOI NATIONALLICENCE 100 1- Neeman Michal Department of Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel aut NATIONALLICENCE 773 0- Cancer and Metastasis Reviews Kluwer Academic Publishers 19/1-2(2000-06-01), 39-43 0167-7659 19:1-2<39 2000 19 10555 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer